• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Seattle Genetics Inc

+ Add to Watchlist

SGEN:US

34.4000 USD 0.4900 1.40%

As of 20:10:00 ET on 07/28/2014.

Snapshot for Seattle Genetics Inc (SGEN)

Open: 35.0000 Day's Range: 33.7500 - 35.2000 Volume: 605,624
Previous Close: 34.8900 52wk Range: 32.3500 - 55.9900 1-Yr Rtn: -13.04%

Stock Chart for SGEN

No chart data available.
  • SGEN:US 34.4500
  • 1D
  • 1M
  • 1Y
34.8900
Interactive SGEN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SGEN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5100
Est. EPS (USD) (12/2014) -0.9060
Est. PEG Ratio -
Market Cap (M USD) 4,236.24
Shares Outstanding (M) 123.15
30 Day Average Volume 1,010,660
Price/Book (mrq) 18.3348
Price/Sale (ttm) 14.9967
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SGEN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SGEN

Seattle Genetics, Inc. discovers and develops monoclonal antibody-based drugs to treat cancer and related diseases. The Company's technologies increase the potency and efficacy of monoclonal antibodies with specificity for cancer.

Clay B SiegallChairman/Pres/CEO/Co-FounderTodd E SimpsonChief Financial Officer
Eric L DobmeierCOO/SecretaryJonathan DrachmanExec VP:Research & Dev
More Company Profile & Key Executives for SGEN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil